Although there appears to be significant therapeutic benefit, it must be remembered that JQ1 is a Brd protein inhibitor35 and that in addition to its effects on MYC has been reported to inhibit the transcriptional activity of STAT544 such that the exact molecular mechanism by which we are achieving preferential extinction of MPN cells is still to be determined. The gene discussed is MYC; the disease is myeloproliferative disorder.